Pfizer CEO Albert Bourla and his vaccine partner BioNTech have said the companies expect phase 3 data by the end of October—and that an FDA application could soon follow. But more than 60 researchers and bioethicists urged the partners to wait for more safety data before submitting their shot for a green light, Bloomberg reports. The experts called on… Read More »
The flu season is going strong. About six million to seven million people in the United States have come down with the illness so far, with half of them sick enough to have seen doctors, according to estimates released on Friday by the Centers for Disease Control and Prevention. Some 69,000 to 84,000 ended up… Read More »
In the name of biological science, it was a particularly big ask. Boston researchers kept seven people in windowless rooms for 37 days. No clocks, radios, televisions, phones or internet. Bedtimes were adjusted so that each night, participants went to sleep four hours later, throwing their body’s circadian rhythms so off balance the effect was… Read More »